Instrument Inactif

Autres langues Vitality Biopharma Inc Other OTC

Actions

US86031Q1040

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

26/04	Range Impact, Inc. annonce des changements au niveau de la direction	CI
29/03	Range Impact, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer	26/04
Range Impact, Inc. Announces Executive Changes	26/04
Range Impact, Inc. Announces Chief Financial Officer Changes	26/04
Range Impact, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
Range Impact, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results	29/03
Range Impact, Inc. Announces Executive Appointments	30/01
Range Impact Announces Former Ohio Congressman Zack Space and Former Ohio Senator Jay Hottinger Have Joined the Company as Strategic Advisors	29/01
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors	21/12
Range Impact, Inc. announced that it has received $1.7 million in funding	21/12
Malachite Innovations Changes its Name to Range Impact and Adopts New Ticker Symbol “RNGE”	14/12
Malachite Innovations, Inc. has Changed its Name to Range Impact, Inc	14/12
Malachite Innovations, Inc. has Changed its Ticker to RNGE from MLCT	14/12
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business	07/12
Graphium Biosciences, Inc. announced that it expects to receive $4 million in funding from Range Impact, Inc.	07/12
Earnings Flash (MLCT) MALACHITE INNOVATIONS Reports Q3 Revenue $5.5M	14/11
Malachite Innovations, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
MALACHITE INNOVATIONS REPORTS THIRD QUARTER 2023 RESULTS	14/11
(MLCT) MALACHITE INNOVATIONS Expects Q4 Revenue $5.5M	14/11
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $1.0 MILLION CAPITAL RAISE TO FUND FIRST ACQUISITION OF FORMER MINE LAND	15/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vitality Biopharma Inc Other OTC

Actions

US86031Q1040

Autres langues

Filtres